Response of oral carcinoma to preoperative methotrexate infusion therapy.
D000818:Animals; D006224:Cricetinae; D004247:DNA / Q000096:biosynthesis; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007269:Injections, Intra-Arterial; D008048:Lip Neoplasms / Q000188:drug therapy / Q000601:surgery; D008099:Liver / Q000378:metabolism; D008297:Male; D008339:Mandibular Neoplasms / Q000188:drug therapy / Q000601:surgery; D008441:Maxillary Neoplasms / Q000188:drug therapy / Q000601:surgery; D008727:Methotrexate / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D009062:Mouth Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000401:mortality / Q000601:surgery; D009092:Mucous Membrane / Q000378:metabolism; D051381:Rats; D013762:Tetrahydrofolate Dehydrogenase / Q000378:metabolism; D014062:Tongue Neoplasms / Q000188:drug therapy / Q000601:surgery; D014067:Tonsillar Neoplasms / Q000188:drug therapy / Q000601:surgery
D004247:DNA; D013762:Tetrahydrofolate Dehydrogenase; D008727:Methotrexate